Get ready for big savings whether you are refreshing your space with small upgrades, like new curtains or sheets, or planning bigger home renovation projects, like remodeling your kitchen or doing a DIY bathroom makeover! If you want to save even more money when you are shopping at IKEA, be sure to join IKEA Family so you can take advantage of our regular furniture sales, amazing deals on home furnishings and special offers on home accessories. So what are you waiting for? Refresh your home with affordable options for the living room, bed, bath and beyond today! Welcome to IKEA, where you will always find affordable furniture, stylish home décor and innovative modern home solutions, as well as design inspiration and unique home ideas! If you are online furniture shopping or if you are visiting a local IKEA store near you, you can expect super low prices on a wide variety of exciting home essentials that are perfect for larger homes and small space living. Orion develops, manufactures and markets human and veterinary medicines and the active ingredients of medicines.Furniture and inspiration for a better everyday life at home Orion is a Finnish pharmaceutical company - a builder of well-being that operates worldwide. We look forward to joining forces and strengthening our presence in the consolidating veterinary industry,” says Jan Moons, CEO of Inovet. I have a very good feeling about the new collaboration with the Orion Veterinary Medicines unit - the mindset and spirit are very similar to ours. “I believe that joining the Orion family will ensure the continued growth of our business. In addition, we are strengthening our manufacturing capabilities, "says Timo Lappalainen, president and CEO of Orion. With this acquisition, Orion Veterinary Medicines will become a comprehensive veterinary company with a broader geographical presence and a wide range of products, covering both companion and production animals. “We are pleased to welcome our new colleagues to the Orion team. The agreement was signed and the transaction was completed simultaneously today, June 15, 2022. Orion will report VMD's net sales as part of the Veterinary Medicines unit's net sales as of June 2022. The impact on the Orion Group's net sales and earnings is not material, and the acquisition will not affect Orion's February 2022 outlook for the full year 2022. The transaction will have a positive effect on the net sales and EBITDA of Orion's Veterinary Medicines unit from 2022 onwards. The immediate cash flow effect is approximately EUR 90 million. The transaction will be financed from Orion's cash resources. The debt-free purchase price is approximately EUR 130 million. In addition, the acquisition supports the Orion Group's growth strategy. Through the acquisition, Orion's Veterinary Medicines unit will expand its product offering and gain a foothold in the production animal market, expand its geographical presence in Western Europe and the export market, and acquire a production facility specializing in the manufacture of veterinary medicines. As a result of the transaction, 181 VMD employees will be transferred to the Orion Group. VMD's turnover in 2021 was EUR 61 million, and the company made a profit. VMD has production facilities in Arques (manufacturing) and Arendonk (packaging) in France, as well as its own sales operations in Belgium, France, Hungary and Vietnam. VMD is headquartered in Arendonk, Belgium. It also has products for companion and other animals. VMD is a veterinary pharmaceutical company specializing in medicines and health products for farm animals. Orion Corporation (Orion), a Finnish pharmaceutical company, has entered into an agreement with the private Belgian company Inovet BV (Inovet), for the acquisition of its wholly owned subsidiary VMD NV and all companies belonging to the VMD NV group. Orion Corporation acquires Inovet's veterinary business You can get e-magazine links on WhatsApp.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |